drugset
drugset / Trial / NCT05187169

Food Effect of VS-6766 in Healthy Adult Subjects

NCT05187169 ↗

Phase 1 Completed 18 enrolled Verastem, Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

An Open-Label, 2-Way, 2-Period Crossover Study of Orally Administered VS-6766 in Healthy Adult Subjects to Determine the Effect of Food on the Pharmacokinetics of VS-6766

Timeline

Start
2021-12-16
Primary completion
2022-04-12
Completion
2022-04-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Avutometinib Small molecule 4 mg Oral

Indications

No indication recorded.